SMI DRUG DISCOVERY LIMITED
Company number 11175710 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£6,652,271
Balance sheet as at 2025-12-31
What it does
Research and experimental development on biotechnology
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-01-29
- Employees
- 14 (2025 accounts · was 13 in 2024)
- Registered office
- Libra Building, 339 Exning Road, Newmarket, Suffolk, United Kingdom, CB8 0AT
- Postcode
- CB8 0AT
- Capital
- 9 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-01-06
- Next due by
- 2027-01-20
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current
Group structure
Controlled by NORCLIFFE NOMINEES LIMITED — since 2022-02-01
From persons-with-significant-control filings on the public register.
Contact details
- Website
- smidrugdiscovery.co.uk
- Phone
- 03031231113
SMi is revolutionising the world of molecular science by coupling deep learning with super-resolution imaging to provide unprecedented quantification of single molecules
Among its peers
Top 10%
by shareholders' funds, of 235 similar companies in CB
Among the biggest employers among its local peers (14 staff).
Trading since 2018.
Competitors Cambridge
This company ranks 21 among research and experimental development on biotechnology in Cambridge.
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.